Search Results 71-80 of 19346 for lupus

  1. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus ...

  2. Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus - Mayo Clinic

    The purpose of this study is to investigate the role of nailfold capillaroscopy in the assessment of patients with Systemic Lupus Erythematosus (SLE).

  3. Overview - Rheumatology - Mayo Clinic Research

    Systemic autoimmune diseases — systemic lupus erythematosus, scleroderma, myositis and related disorders. Inflammatory arthritis — rheumatoid arthritis ...

  4. Mayo Rheumatologist Dr. Timothy Niewold Recognized for Achievements in Lupus Research

    Timothy Niewold has received the Lupus Foundation of America's Mary Betty Stevens Young Investigator Prize for his research on the autoimmune disease lupus. Dr.

  5. MONDAY HOUSECALL: Stress and Blood Pressure, Emotional Eating, Lupus and more ...

    MONDAY HOUSECALL: Stress and Blood Pressure, Emotional Eating, Lupus and more … ... Lupus: Can it cause hair loss? Fiber supplements: Safe to take every day ...

  6. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: Lupus rates increasing, communities of color especially vulnerable featured image. Science Saturday. Science Saturday: Lupus rates ...

  7. Pediatric rheumatology - Overview - Mayo Clinic

    Lupus · Sjogren's syndrome; Localized scleroderma (morphea); Vasculitis · Kawasaki disease · Henoch-Schönlein purpura · Familial Mediterranean fever.

  8. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis ... Lupus Nephritis (LN).

  9. A Study Of The Safety And Tolerability Of JNJ-55920839, Either As A Single Ascending Dose In Healthy Individuals Or As Multiple Doses For Patients Who Have Mild To Moderate Systemic Lupus Erythematosus - Mayo Clinic

    ... Lupus International Collaborating Clinics (SLICC) criteria for diagnosis of lupus ... Has active Central nervous system (CNS) lupus or history of severe CNS lupus ...

  10. Cynthia S. Crowson, Ph.D. - Mayo Clinic Faculty Profiles

    Her research is focused on the epidemiology of rheumatic diseases with special interests in rheumatoid arthritis and systemic lupus erythematosus. As a ...